Vitamin K Antagonists Market
1 Study Coverage
1.1 Vitamin K Antagonists (VKA) Product Introduction
1.2 Market by Type
1.2.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Vitamin K Antagonists
1.2.3 Injection Vitamin K Antagonists
1.3 Market by Application
1.3.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vitamin K Antagonists (VKA) Sales Estimates and Forecasts 2017-2028
2.2 Global Vitamin K Antagonists (VKA) Revenue Estimates and Forecasts 2017-2028
2.3 Global Vitamin K Antagonists (VKA) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vitamin K Antagonists (VKA) Sales by Region
2.4.1 Global Vitamin K Antagonists (VKA) Sales by Region (2017-2022)
2.4.2 Global Sales Vitamin K Antagonists (VKA) by Region (2023-2028)
2.5 Global Vitamin K Antagonists (VKA) Revenue by Region
2.5.1 Global Vitamin K Antagonists (VKA) Revenue by Region (2017-2022)
2.5.2 Global Vitamin K Antagonists (VKA) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vitamin K Antagonists (VKA) Sales by Manufacturers
3.1.1 Global Top Vitamin K Antagonists (VKA) Manufacturers by Sales (2017-2022)
3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vitamin K Antagonists (VKA) in 2021
3.2 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers
3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers (2017-2022)
3.2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vitamin K Antagonists (VKA) Revenue in 2021
3.3 Global Vitamin K Antagonists (VKA) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vitamin K Antagonists (VKA) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vitamin K Antagonists (VKA) Sales by Type
4.1.1 Global Vitamin K Antagonists (VKA) Historical Sales by Type (2017-2022)
4.1.2 Global Vitamin K Antagonists (VKA) Forecasted Sales by Type (2023-2028)
4.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
4.2 Global Vitamin K Antagonists (VKA) Revenue by Type
4.2.1 Global Vitamin K Antagonists (VKA) Historical Revenue by Type (2017-2022)
4.2.2 Global Vitamin K Antagonists (VKA) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
4.3 Global Vitamin K Antagonists (VKA) Price by Type
4.3.1 Global Vitamin K Antagonists (VKA) Price by Type (2017-2022)
4.3.2 Global Vitamin K Antagonists (VKA) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vitamin K Antagonists (VKA) Sales by Application
5.1.1 Global Vitamin K Antagonists (VKA) Historical Sales by Application (2017-2022)
5.1.2 Global Vitamin K Antagonists (VKA) Forecasted Sales by Application (2023-2028)
5.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
5.2 Global Vitamin K Antagonists (VKA) Revenue by Application
5.2.1 Global Vitamin K Antagonists (VKA) Historical Revenue by Application (2017-2022)
5.2.2 Global Vitamin K Antagonists (VKA) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
5.3 Global Vitamin K Antagonists (VKA) Price by Application
5.3.1 Global Vitamin K Antagonists (VKA) Price by Application (2017-2022)
5.3.2 Global Vitamin K Antagonists (VKA) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vitamin K Antagonists (VKA) Market Size by Type
6.1.1 North America Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
6.1.2 North America Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
6.2 North America Vitamin K Antagonists (VKA) Market Size by Application
6.2.1 North America Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
6.2.2 North America Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
6.3 North America Vitamin K Antagonists (VKA) Market Size by Country
6.3.1 North America Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
6.3.2 North America Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vitamin K Antagonists (VKA) Market Size by Type
7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
7.2 Europe Vitamin K Antagonists (VKA) Market Size by Application
7.2.1 Europe Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
7.2.2 Europe Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
7.3 Europe Vitamin K Antagonists (VKA) Market Size by Country
7.3.1 Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
7.3.2 Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Type
8.1.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
8.1.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
8.2 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Application
8.2.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
8.2.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
8.3 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Region
8.3.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2017-2028)
8.3.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vitamin K Antagonists (VKA) Market Size by Type
9.1.1 Latin America Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
9.1.2 Latin America Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
9.2 Latin America Vitamin K Antagonists (VKA) Market Size by Application
9.2.1 Latin America Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
9.2.2 Latin America Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
9.3 Latin America Vitamin K Antagonists (VKA) Market Size by Country
9.3.1 Latin America Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
9.3.2 Latin America Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Type
10.1.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
10.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Application
10.2.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
10.3 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Country
10.3.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Corporation Information
11.5.2 Genentech (Roche) Overview
11.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Genentech (Roche) Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Lilly
11.7.1 Lilly Corporation Information
11.7.2 Lilly Overview
11.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lilly Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lilly Recent Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Corporation Information
11.8.2 Daiichi Sankyo Overview
11.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Daiichi Sankyo Recent Developments
11.9 Otsuka
11.9.1 Otsuka Corporation Information
11.9.2 Otsuka Overview
11.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Otsuka Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Otsuka Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Pfizer
11.11.1 Pfizer Corporation Information
11.11.2 Pfizer Overview
11.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pfizer Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Recent Developments
11.12 Aspen
11.12.1 Aspen Corporation Information
11.12.2 Aspen Overview
11.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aspen Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aspen Recent Developments
11.13 The Medicines Company
11.13.1 The Medicines Company Corporation Information
11.13.2 The Medicines Company Overview
11.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 The Medicines Company Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 The Medicines Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vitamin K Antagonists (VKA) Industry Chain Analysis
12.2 Vitamin K Antagonists (VKA) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vitamin K Antagonists (VKA) Production Mode & Process
12.4 Vitamin K Antagonists (VKA) Sales and Marketing
12.4.1 Vitamin K Antagonists (VKA) Sales Channels
12.4.2 Vitamin K Antagonists (VKA) Distributors
12.5 Vitamin K Antagonists (VKA) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vitamin K Antagonists (VKA) Industry Trends
13.2 Vitamin K Antagonists (VKA) Market Drivers
13.3 Vitamin K Antagonists (VKA) Market Challenges
13.4 Vitamin K Antagonists (VKA) Market Restraints
14 Key Findings in The Global Vitamin K Antagonists (VKA) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Vitamin K Antagonists
Table 3. Major Manufacturers of Injection Vitamin K Antagonists
Table 4. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vitamin K Antagonists (VKA) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vitamin K Antagonists (VKA) Sales by Region (2017-2022) & (K MT)
Table 7. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)
Table 8. Global Vitamin K Antagonists (VKA) Sales by Region (2023-2028) & (K MT)
Table 9. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2023-2028)
Table 10. Global Vitamin K Antagonists (VKA) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2017-2022)
Table 12. Global Vitamin K Antagonists (VKA) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2023-2028)
Table 14. Global Vitamin K Antagonists (VKA) Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturers (2017-2022)
Table 16. Global Vitamin K Antagonists (VKA) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2017-2022)
Table 18. Vitamin K Antagonists (VKA) Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2021)
Table 21. Vitamin K Antagonists (VKA) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vitamin K Antagonists (VKA) Product Offered
Table 23. Date of Manufacturers Enter into Vitamin K Antagonists (VKA) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 26. Global Vitamin K Antagonists (VKA) Sales by Type (2023-2028) & (K MT)
Table 27. Global Vitamin K Antagonists (VKA) Sales Share by Type (2017-2022)
Table 28. Global Vitamin K Antagonists (VKA) Sales Share by Type (2023-2028)
Table 29. Global Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Vitamin K Antagonists (VKA) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Vitamin K Antagonists (VKA) Revenue Share by Type (2017-2022)
Table 32. Global Vitamin K Antagonists (VKA) Revenue Share by Type (2023-2028)
Table 33. Vitamin K Antagonists (VKA) Price by Type (2017-2022) & (USD/MT)
Table 34. Global Vitamin K Antagonists (VKA) Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 36. Global Vitamin K Antagonists (VKA) Sales by Application (2023-2028) & (K MT)
Table 37. Global Vitamin K Antagonists (VKA) Sales Share by Application (2017-2022)
Table 38. Global Vitamin K Antagonists (VKA) Sales Share by Application (2023-2028)
Table 39. Global Vitamin K Antagonists (VKA) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vitamin K Antagonists (VKA) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vitamin K Antagonists (VKA) Revenue Share by Application (2017-2022)
Table 42. Global Vitamin K Antagonists (VKA) Revenue Share by Application (2023-2028)
Table 43. Vitamin K Antagonists (VKA) Price by Application (2017-2022) & (USD/MT)
Table 44. Global Vitamin K Antagonists (VKA) Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 46. North America Vitamin K Antagonists (VKA) Sales by Type (2023-2028) & (K MT)
Table 47. North America Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Vitamin K Antagonists (VKA) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 50. North America Vitamin K Antagonists (VKA) Sales by Application (2023-2028) & (K MT)
Table 51. North America Vitamin K Antagonists (VKA) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vitamin K Antagonists (VKA) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 54. North America Vitamin K Antagonists (VKA) Sales by Country (2023-2028) & (K MT)
Table 55. North America Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vitamin K Antagonists (VKA) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 58. Europe Vitamin K Antagonists (VKA) Sales by Type (2023-2028) & (K MT)
Table 59. Europe Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Vitamin K Antagonists (VKA) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 62. Europe Vitamin K Antagonists (VKA) Sales by Application (2023-2028) & (K MT)
Table 63. Europe Vitamin K Antagonists (VKA) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vitamin K Antagonists (VKA) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 66. Europe Vitamin K Antagonists (VKA) Sales by Country (2023-2028) & (K MT)
Table 67. Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vitamin K Antagonists (VKA) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Vitamin K Antagonists (VKA) Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Vitamin K Antagonists (VKA) Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Vitamin K Antagonists (VKA) Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Vitamin K Antagonists (VKA) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Vitamin K Antagonists (VKA) Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Vitamin K Antagonists (VKA) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vitamin K Antagonists (VKA) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Vitamin K Antagonists (VKA) Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Sanofi Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Major Businesses
Table 112. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bristol-Myers Squibb Recent Developments
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Bayer Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bayer Recent Developments
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Major Businesses
Table 122. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Johnson & Johnson Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Johnson & Johnson Recent Developments
Table 125. Genentech (Roche) Corporation Information
Table 126. Genentech (Roche) Description and Major Businesses
Table 127. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Genentech (Roche) Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Genentech (Roche) Recent Developments
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Major Businesses
Table 132. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Boehringer Ingelheim Recent Developments
Table 135. Lilly Corporation Information
Table 136. Lilly Description and Major Businesses
Table 137. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Lilly Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Lilly Recent Developments
Table 140. Daiichi Sankyo Corporation Information
Table 141. Daiichi Sankyo Description and Major Businesses
Table 142. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Daiichi Sankyo Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Daiichi Sankyo Recent Developments
Table 145. Otsuka Corporation Information
Table 146. Otsuka Description and Major Businesses
Table 147. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Otsuka Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Otsuka Recent Developments
Table 150. AstraZeneca Corporation Information
Table 151. AstraZeneca Description and Major Businesses
Table 152. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. AstraZeneca Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. AstraZeneca Recent Developments
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Major Businesses
Table 157. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. Pfizer Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Pfizer Recent Developments
Table 160. Aspen Corporation Information
Table 161. Aspen Description and Major Businesses
Table 162. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 163. Aspen Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Aspen Recent Developments
Table 165. The Medicines Company Corporation Information
Table 166. The Medicines Company Description and Major Businesses
Table 167. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 168. The Medicines Company Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. The Medicines Company Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Vitamin K Antagonists (VKA) Distributors List
Table 173. Vitamin K Antagonists (VKA) Customers List
Table 174. Vitamin K Antagonists (VKA) Market Trends
Table 175. Vitamin K Antagonists (VKA) Market Drivers
Table 176. Vitamin K Antagonists (VKA) Market Challenges
Table 177. Vitamin K Antagonists (VKA) Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitamin K Antagonists (VKA) Product Picture
Figure 3. Global Vitamin K Antagonists (VKA) Market Share by Type in 2021 & 2028
Figure 3. Oral Vitamin K Antagonists Product Picture
Figure 4. Injection Vitamin K Antagonists Product Picture
Figure 5. Global Vitamin K Antagonists (VKA) Market Share by Application in 2021 & 2028
Figure 6. VTE
Figure 7. ACS/MI
Figure 8. AF
Figure 9. Others
Figure 10. Vitamin K Antagonists (VKA) Report Years Considered
Figure 11. Global Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT)
Figure 12. Global Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Vitamin K Antagonists (VKA) Revenue 2017-2028 (US$ Million)
Figure 14. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)
Figure 16. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2023-2028)
Figure 17. North America Vitamin K Antagonists (VKA) Sales YoY (2017-2028) & (K MT)
Figure 18. North America Vitamin K Antagonists (VKA) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Vitamin K Antagonists (VKA) Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Vitamin K Antagonists (VKA) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Vitamin K Antagonists (VKA) Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Vitamin K Antagonists (VKA) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Vitamin K Antagonists (VKA) Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Vitamin K Antagonists (VKA) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Vitamin K Antagonists (VKA) Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Vitamin K Antagonists (VKA) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Vitamin K Antagonists (VKA) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Vitamin K Antagonists (VKA) in the World: Market Share by Vitamin K Antagonists (VKA) Revenue in 2021
Figure 29. Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
Figure 31. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
Figure 32. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
Figure 33. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
Figure 34. North America Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
Figure 35. North America Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
Figure 36. North America Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
Figure 37. North America Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
Figure 38. North America Vitamin K Antagonists (VKA) Sales Share by Country (2017-2028)
Figure 39. North America Vitamin K Antagonists (VKA) Revenue Share by Country (2017-2028)
Figure 40. U.S. Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
Figure 43. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
Figure 45. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Vitamin K Antagonists (VKA) Sales Share by Country (2017-2028)
Figure 47. Europe Vitamin K Antagonists (VKA) Revenue Share by Country (2017-2028)
Figure 48. Germany Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 49. France Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Vitamin K Antagonists (VKA) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Vitamin K Antagonists (VKA) Revenue Share by Region (2017-2028)
Figure 59. China Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 62. India Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Vitamin K Antagonists (VKA) Sales Share by Country (2017-2028)
Figure 74. Latin America Vitamin K Antagonists (VKA) Revenue Share by Country (2017-2028)
Figure 75. Mexico Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Vitamin K Antagonists (VKA) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Share by Country (2017-2028)
Figure 84. Turkey Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Vitamin K Antagonists (VKA) Revenue (2017-2028) & (US$ Million)
Figure 87. Vitamin K Antagonists (VKA) Value Chain
Figure 88. Vitamin K Antagonists (VKA) Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
